<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02384551</url>
  </required_header>
  <id_info>
    <org_study_id>CLNB-006-14S</org_study_id>
    <nct_id>NCT02384551</nct_id>
  </id_info>
  <brief_title>Dietary Carbohydrate and GERD in Veterans</brief_title>
  <acronym>DietGERD</acronym>
  <official_title>Dietary Carbohydrate Effects on GERD in Obese Veterans: Nutritional or Hormonal?</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>VA Office of Research and Development</agency>
      <agency_class>U.S. Fed</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>VA Office of Research and Development</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      4-Arm Diet Intervention Investigating Effects of Dietary Carbohydrate Type and Amount on&#xD;
      gastroesophageal pH, gastroesophageal reflux disease (GERD) symptoms and medication use.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      delayed due to COVID related research shutdown&#xD;
&#xD;
      Specific Hypothesis: The preliminary findings suggest a physiological mechanism between&#xD;
      dietary intake and GERD that may be related to type of dietary carbohydrate intake (complex&#xD;
      vs simple carbohydrate). The investigators hypothesize that modifying the type of dietary&#xD;
      carbohydrate consumed - by reducing the proportion of simple carbohydrate (sugars) consumed -&#xD;
      will reduce or resolve GERD symptoms and medication use in obese Veterans with chronic GERD.&#xD;
      The investigators further hypothesize that the mechanistic effects of reducing simple&#xD;
      carbohydrate intake is related to either: a) improved dietary fiber intake and/or glycemic&#xD;
      load, and thus, reduced amount and duration of esophageal acid exposure; and/or b) improved&#xD;
      insulin sensitivity which would positively influence the function of key gastrointestinal&#xD;
      hormones (ie, gastrin, glucagon, GLP-1, ghrelin11) that regulate gastric motility and/or&#xD;
      lower esophageal sphincter function.&#xD;
&#xD;
      Aim 1: To determine effects of dietary carbohydrate consumed (amount and type) on percent&#xD;
      time with esophageal pH &lt; 4.0, as well as number of reflux episodes, GERD symptoms and GERD&#xD;
      medication use, in 200 obese Veterans who have chronic high frequency of GERD symptoms. To&#xD;
      meet this aim the investigators will use a randomized controlled trial in which the&#xD;
      investigators manipulate amount of total and simple dietary carbohydrate intake for duration&#xD;
      of 9 weeks.&#xD;
&#xD;
      Aim 2: To assess associations between GERD resolution variables and factors related to&#xD;
      potential mechanisms by which modifying dietary carbohydrate intake could resolve/reduce GERD&#xD;
      in obese Veterans.&#xD;
&#xD;
      2a: The investigators will investigate associations related to whether the effect is&#xD;
      nutritionally mediated by measuring change in dietary fiber load and dietary glycemic load,&#xD;
      and thus, whether these changes are related to improved gastric acid secretion (% time pH &lt;&#xD;
      4), gastric motility, and/or the other parameters that comprise the Johnson-DeMeester score.&#xD;
&#xD;
      2b: The investigators will also investigate whether effects are associated with changes in&#xD;
      the hormonal milieu by measuring hormonal response of gastrin, glucagon, glucagon-like&#xD;
      peptide-1 (GLP-1), ghrelin and insulin, which could potentially influence gastric acid&#xD;
      secretion, gastric motility and/or lower esophageal sphincter function.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">January 25, 2016</start_date>
  <completion_date type="Anticipated">December 31, 2021</completion_date>
  <primary_completion_date type="Actual">September 30, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Gastroesophageal pH</measure>
    <time_frame>24 hours</time_frame>
    <description>ambulatory ph monitoring for gastroesophageal ph, number and frequency of reflux episodes</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>GERD symptoms</measure>
    <time_frame>9 weeks</time_frame>
    <description>GERD symptoms measured weekly for 9 weeks using Gastroesophageal Reflux Disease Symptom Assessment Scale (GSAS)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>GERD medication use</measure>
    <time_frame>9 weeks</time_frame>
    <description>Weekly measure of type, amount and dose of GERD medication use</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>GERD symptoms</measure>
    <time_frame>9 weeks</time_frame>
    <description>GERD symptoms measured weekly for 9 weeks using Gastroesophageal Reflux Disease Questionnaire (GERDQ)</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Gastric hormones</measure>
    <time_frame>24 hour period</time_frame>
    <description>Plasma/serum measure of glucose, insulin, gastrin, glucagon, active ghrelin and active GLP-1</description>
  </other_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">90</enrollment>
  <condition>Gastroesophageal Reflux Disease</condition>
  <condition>Obesity</condition>
  <arm_group>
    <arm_group_label>HTHS</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>High total carbohydrate with high total simple carbohydrate diet</description>
  </arm_group>
  <arm_group>
    <arm_group_label>HTLS</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>High total carbohydrate with low total simple carbohydrate diet</description>
  </arm_group>
  <arm_group>
    <arm_group_label>LTHS</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Low total carbohydrate with low total simple carbohydrate diet</description>
  </arm_group>
  <arm_group>
    <arm_group_label>LTLS</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Low total carbohydrate with low total simple carbohydrate diet</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Dietary Carbohydrate</intervention_name>
    <description>9 week menu of dietary carbohydrate modification</description>
    <arm_group_label>HTHS</arm_group_label>
    <arm_group_label>HTLS</arm_group_label>
    <arm_group_label>LTHS</arm_group_label>
    <arm_group_label>LTLS</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        Age 21 or over BMI 30-39.9 GERD&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  History of type 1 diabetes&#xD;
&#xD;
          -  Hernia or strictures&#xD;
&#xD;
          -  Gastroparesis&#xD;
&#xD;
          -  Extra-esophageal GERD&#xD;
&#xD;
          -  Barrett's esophagus or Esophageal adenocarcinoma&#xD;
&#xD;
          -  History of gastric or bariatric or esophageal surgery, radiation or cancer&#xD;
&#xD;
          -  History of gastrointestinal malabsorption&#xD;
&#xD;
          -  Alcohol averaging &gt; 2 drinks per day during past 3 months&#xD;
&#xD;
          -  Pregnancy / Lactation&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kevin D Niswender, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Tennessee Valley Healthcare System Nashville Campus, Nashville, TN</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Tennessee Valley Healthcare System Nashville Campus, Nashville, TN</name>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <zip>37212-2637</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>March 4, 2015</study_first_submitted>
  <study_first_submitted_qc>March 4, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 10, 2015</study_first_posted>
  <last_update_submitted>October 19, 2021</last_update_submitted>
  <last_update_submitted_qc>October 19, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 22, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>GERD</keyword>
  <keyword>diet</keyword>
  <keyword>carbohydrate</keyword>
  <keyword>obesity</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Gastroesophageal Reflux</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>Data will be provided as group data upon publication</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

